½ÃÀ庸°í¼­
»óǰÄÚµå
1813945

¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, ±¸¼º¿ä¼Òº°, ¹èÆ÷ ¹æ½Äº°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2025-2033³â)

U.S. Healthcare Analytics Market Size, Share & Trends Analysis Report By Type (Descriptive Analysis, Predictive Analysis), By Component (Software, Hardware), By Delivery Mode, By Application, By End-use, And Segment Forecasts, 2025 - 2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 90 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå ¿ä¾à

¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 2121¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2033³â¿¡´Â 674¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2033³â±îÁö 12.76%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¹è°æ¿¡´Â ºñ¿ë Àý°¨¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, °¡Ä¡ ±â¹Ý Áø·áÀÇ µµÀÔ, µ¥ÀÌÅÍ »óÈ£¿î¿ë¼º °ü·Ã ±ÔÁ¦ Àǹ«È­ µîÀÌ ÀÖ½À´Ï´Ù.

ÀÓ»ó °á°ú °³¼±, Áý´Ü°Ç°­°ü¸®, ¾÷¹« °£¼ÒÈ­¸¦ À§ÇÑ AI ¹× ¿¹Ãø ºÐ¼®ÀÇ »ç¿ëÀÌ Áõ°¡Çϸ鼭 ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, EHR µµÀÔÀÇ È®´ë¿Í ÁöºÒÀÚ¿Í ÀÇ·á°ø±ÞÀÚÀÇ ¿¬°è°¡ ½ÃÀå ħÅõ¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ÀÇ ÇコÄÉ¾î ºÐ¼® »ê¾÷Àº ±¤¹üÀ§ÇÑ µðÁöÅÐÈ­¿Í »óÈ£¿î¿ë¼ºÀ» ÃËÁøÇÏ´Â Á¤ºÎ Àμ¾Æ¼ºê¿¡ ÈûÀÔ¾î ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. The Assistant Secretary for Technology Policy/Office¿¡ µû¸£¸é, 2021³â ±âÁØÀ¸·Î ¿¬¹æÁ¤ºÎ¸¦ Á¦¿ÜÇÑ ±Þ¼º±â º´¿øÀÇ °ÅÀÇ ¸ðµç º´¿ø(96%)°ú ±Ù¹« ÀÇ»çÀÇ ¾à 78%°¡ ÀÎÁõµÈ ÀüÀڰǰ­±â·Ï(EHR)À» µµÀÔÇϰí ÀÖÀ¸¸ç, µµÀÔ·üÀÌ º´¿ø 28%, ÀÇ»ç 34%¿¡ ºÒ°úÇß´ø 2011³â¿¡ ºñÇØ Å©°Ô Áõ°¡Çß½À´Ï´Ù. 34%¿¡ ºÒ°úÇß´ø 2011³â¿¡ ºñÇØ Å©°Ô Áõ°¡ÇÏ¿´½À´Ï´Ù. ÀÌ·¯ÇÑ ºü¸¥ ÀüȯÀº ºÐ¼®À» À§ÇÑ °ß°íÇÑ µðÁöÅÐ ±â¹ÝÀ» ±¸ÃàÇßÀ¸¸ç, ÇコÄɾî ȯ°æ Àü¹ÝÀÇ µ¥ÀÌÅÍ ±³È¯ °³¼±¿¡ ÃÊÁ¡À» ¸ÂÃá Á¤Ã¥À¸·Î ´õ¿í °­È­µÇ¾ú½À´Ï´Ù. ÇÑÆí, ÇコÄÉ¾î ¸®´õµéÀº °¡Ä¡ ±â¹Ý ÀǷḦ µµÀÔÇϰí, ºÐ¼®À» Ȱ¿ëÇÏ¿© Áø·á º¸»óÀ» °á°ú¿Í ¿¬°áÇϰí, ÀçÀÔ¿øÀ²À» ³·Ã߸ç, Áý´Ü°Ç°­°ü¸®¸¦ °­È­Çϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ÇコÄÉ¾î ¾÷°èÀÇ IT °³¹ß ¹× µðÁöÅÐÈ­¿¡ ´ëÇÑ ´ë±Ô¸ð ÅõÀÚ´Â ÇコÄÉ¾î ºÐ¼® »ê¾÷ÀÇ ³î¶ó¿î ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. 2021³â 1¿ù, Optum, Inc.´Â ±â¼úÀ» Ȱ¿ëÇÑ ÇコÄɾî Ç÷§ÆûÀ» ÃßÁøÇϱâ À§ÇØ Ã¼ÀÎÁö ÇコÄɾî¿Í ÆÄÆ®³Ê½ÊÀ» ¸Î¾ú½À´Ï´Ù. ¾ç»ç´Â µ¥ÀÌÅÍ ºÐ¼® ¼Ö·ç¼Ç, ¼ÒÇÁÆ®¿þ¾î, ±â¼úÀûÀ¸·Î Áøº¸µÈ ÇコÄɾî Ç÷§ÆûÀ» ¼ÒºñÀÚ¿¡°Ô Á¦°øÇÕ´Ï´Ù. ÇöÀç Àü ¼¼°è ÀÇ·á±â°ü¿¡¼­ µµÀԵǰí ÀÖ´Â ºÐ¼® Ç÷§ÆûÀº ȯÀÚ °ü¸®¿Í ȯÀÚ À¯Áö¿¡ µµ¿òÀ» ÁÖ°í, ´õ ³ªÀº Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇコÄÉ¾î ºÐ¼® Ç÷§ÆûÀÇ µµÀÔÀº Á÷¿øÀÇ »ý»ê¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó Àü¹ÝÀûÀΠȯÀÚ °ü¸®¸¦ °³¼±ÇÏ°í °£º´ÀÎÀÇ ºÎ´ãÀ» ÃÖ¼ÒÈ­ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ¾÷°è ±âȸ ºÐ¼®
    • ¾÷°è °úÁ¦ ºÐ¼®
    • »ç·Ê ¿¬±¸
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • À¯Çü ºÎ¹® ´ë½Ãº¸µå
  • À¯Çü ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®(À¯Çüº°, 2021-2033³â)
  • ±â¼ú ºÐ¼®
  • Áø´Ü ºÐ¼®
  • ¿¹Ãø ºÐ¼®
  • ±Ô¹üÀû ºÐ¼®

Á¦5Àå ¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå : ±¸¼º¿ä¼Ò ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÄÄÆ÷³ÍÆ® ºÎ¹® ´ë½Ãº¸µå
  • ÄÄÆ÷³ÍÆ® ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®(±¸¼º¿ä¼Òº°, 2021-2033³â)
  • ¼ÒÇÁÆ®¿þ¾î
  • Çϵå¿þ¾î
  • ¼­ºñ½º

Á¦6Àå ¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå : ¹èÆ÷ ¹æ½Ä ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¹èÆ÷ ¹æ½Ä ´ë½Ãº¸µå
  • ¹èÆ÷ ¹æ½Ä ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®(¹èÆ÷ ¹æ½Äº°, 2021-2033³â)
  • ¿ÂÇÁ·¹¹Ì½º
  • À¥ È£½ºÆ®
  • Ŭ¶ó¿ìµå ±â¹Ý

Á¦7Àå ¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ¿ëµµ ¸ðµå ´ë½Ãº¸µå
  • ¿ëµµ ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®(¿ëµµº°, 2021-2033³â)
  • ÀÓ»ó
  • À繫
  • ¿î¿µ ¹× °ü¸®

Á¦8Àå ¹Ì±¹ÀÇ ÇコÄÉ¾î ¾Ö³Î¸®Æ½½º ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À² º¯µ¿ ºÐ¼®, 2024³â ¹× 2033³â
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø, µ¿Ç⠺м®(ÃÖÁ¾ ¿ëµµº°, 2021-2033³â)
  • ÇコÄɾî Á¦°øÀÚ
  • ÀÇ·á ÁöºÒÀÚ
  • »ý¸í°úÇÐ ±â¾÷

Á¦9Àå °æÀï ±¸µµ

  • Âü¿©ÀÚ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
    • Oracle
    • McKesson Corporation
    • Optum, Inc.
    • IBM
    • SAS Institute, Inc.
    • IQVIA
    • Verisk Analytics, Inc.
    • Elsevier
    • Medeanalytics, Inc.
    • Truven Health Analytics, Inc.
    • Allscripts Healthcare Solutions, Inc
KSM 25.09.26

U.S. Healthcare Analytics Market Summary

The U.S. healthcare analytics market size was estimated at USD 21.21 billion in 2024 and is projected to reach USD 67.48 billion by 2033, growing at a CAGR of 12.76% from 2025 to 2033. This growth is attributed to the rising need for cost containment, value-based care adoption, and regulatory mandates for data interoperability.

Increasing use of AI and predictive analytics to improve clinical outcomes, manage population health, and streamline operations further fuels demand. In addition, expanding EHR adoption and payer-provider alignment accelerate market penetration. The U.S. healthcare analytics industry is expanding rapidly, driven by government incentives that promote widespread digitization and interoperability. According to The Assistant Secretary for Technology Policy/Office, as of 2021, nearly all non-federal acute care hospitals (96%) and about 78% of office-based physicians had implemented certified electronic health records (EHRs), a significant increase from 2011, when adoption was just 28% for hospitals and 34% for physicians. This swift transition has established a solid digital foundation for analytics, further strengthened by policies focused on improving data exchange across healthcare environments. Meanwhile, healthcare leaders are adopting value-based care, using analytics to link reimbursement with outcomes, lower readmission rates, and enhance population health management.

A rapid rate of technological advancements and massive investments by the healthcare industry into IT development and digitization have been key factors for the monumental growth of the healthcare analytics industry. In January 2021, Optum, Inc. collaborated with Change Healthcare to advance the technology-enabled healthcare platform. Both companies provide their consumers with data analytics solutions, software, and a technology-advanced healthcare platform. Analytical platforms that are currently being deployed by healthcare institutions across the globe help in patient management, their retention, due to which better care can be delivered. Deployment of healthcare analytical platforms not only increases the productivity of staff, but overall patient management has been improved, and the burden on caregivers has been minimized.

U.S. Healthcare Analytics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare analytics market report based on type, component, delivery mode, application, and end use:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Descriptive Analysis
  • Diagnostic Analytics
  • Predictive Analysis
  • Prescriptive Analysis
  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Hardware
  • Services
  • Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • On-premises
  • Web-hosted
  • Cloud-based
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical
  • Financial
  • Operational & Administrative
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Healthcare Payers
  • Healthcare Providers
  • Life Science Companies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Component
    • 1.2.3. Delivery mode
    • 1.2.4. Application
    • 1.2.5. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Pressure to Curb Healthcare Cost
      • 3.2.1.2. Emergence of Advanced Analytics Method
      • 3.2.1.3. Growing Demand for Personalized Medication and Treatment
      • 3.2.1.4. Rising Impact of Internet and Social Media On Healthcare
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Data Privacy and Theft Issues
      • 3.2.2.2. Lack of Skilled Professionals
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Case Studies
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. U.S. Healthcare Analytics Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Type Market Share Movement Analysis, 2024 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Descriptive Analysis
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Diagnostic Analytics
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Predictive Analysis
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Prescriptive Analysis
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Healthcare Analytics Market: Component Estimates & Trend Analysis

  • 5.1. Component Segment Dashboard
  • 5.2. Component Market Share Movement Analysis, 2024 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by Component, 2021 to 2033 (USD Million)
  • 5.4. Software
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Hardware
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Services
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Healthcare Analytics Market: Delivery Mode Estimates & Trend Analysis

  • 6.1. Delivery Mode Dashboard
  • 6.2. Delivery Mode Market Share Movement Analysis, 2024 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Delivery Mode, 2021 to 2033 (USD Million)
  • 6.4. On-premise
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Web-hosted
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Cloud-based
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Healthcare Analytics Market: Application Estimates & Trend Analysis

  • 7.1. Application Mode Dashboard
  • 7.2. Application Market Share Movement Analysis, 2024 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Clinical
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Financial
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Operational and Administrative
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Healthcare Analytics Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. End Use Market Share Movement Analysis, 2024 & 2033
  • 8.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Healthcare Providers
    • 8.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Healthcare Payers
    • 8.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Life Sciences Companies
    • 8.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Oracle
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. McKesson Corporation
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Optum, Inc.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. IBM
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. SAS Institute, Inc.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. IQVIA
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Verisk Analytics, Inc.
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Elsevier
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Medeanalytics, Inc.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Truven Health Analytics, Inc.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Allscripts Healthcare Solutions, Inc
      • 9.5.11.1. Overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦